The Pharma Data

MARCH 25, 2021

IBRANCE is an oral inhibitor of CDKs 4 and 6, 1 which are key regulators of the cell cycle that trigger cellular progression. IBRANCE may impair fertility in males and has the potential to cause genotoxicity. Pfizer will continue to share new data from these studies with the scientific community as results becomes available.

HR 52

HR Clinical Trials Clinical Trials Trials 52

The Pharma Data

FEBRUARY 8, 2021

IBRANCE is an oral inhibitor of CDKs 4 and 6, 1 which are key regulators of the cell cycle that trigger cellular progression. IBRANCE may impair fertility in males and has the potential to cause genotoxicity. This extension does not include potential pediatric exclusivity. About IBRANCE® (palbociclib) 125 mg tablets and capsules.

HR 52

HR Clinical Trials Clinical Trials Containment 52

The Pharma Data

MAY 13, 2021

The trans-fat ban–food regulation and long-term health. Exposure to sorbitol during lactation causes metabolic alterations and genotoxic effects in rat offspring. Regulation of glucose metabolism from a liver-centric perspective. The role of ghrelin in weight-regulation disorders: implications in clinical practice.

Insulin 52

Insulin Production Hormones Medicine 52